A Comprehensive Single Institutional Review of 2 Years in a Designated Fast-Track Sarcoma Diagnostic Clinic Linked with a Sarcoma Specialist Advisory Group: Meeting the Target but Failing the Task?

Table 1

Diagnostic pathways and results.

	Method of diagnosis	BT	T	I	BE	P	M	S	SM	Total
Local	Clinical	1	1	1	2					5
	Excisional biopsy, plastic surgeon	84		5	12	1		4		106
	Histology, colorectal surgeon						1			1
	Histology, neurosurgeon		1					1		2
	Histology, orthopaedics	1							2	3
	Biopsy (radiology guided)	10		5	4	12	7	7		45
	BMT					2				2
	Radiological	74	16	20	60		3	1		173
	Total	170	18	31	78	13	11	15	2	338
	% (of all local)	50.29	5.32	9.17	23.07	3.84	3.25	4.43	0.59	100
Supraregional	Histology, Bham	14	1			2		21	2	43
	Histology, Pworth	1				1	1	3		5
	Radiological, Bham	6			4			2		10
	Radiological, RMH	1								1
	Total	22	1		4	3	1	26	2	59
	% (of all supraregional)	7.28	1.69	0	6.77	5.08	1.69	44.06	1.69	100
All	Total	192	19	31	82	16	12	41	4	397
	% (of all)	48.36	4.78	7.80	20.65	4.03	3.02	10.32	0.75	100

BT: benign tumours, T: traumatic lesion, I: inflammatory/infective lesions, BE: benign lesions of nontumorous nature or no abnormality detected, P: primary cancer, M: metastatic cancer, S: sarcoma, SM: semimalignant tumour, BMT: bone marrow trephine, Bham: Royal Orthopaedic Hospital Birmingham or the Midland Abdominal and Retroperitoneal Sarcoma Unit (MARSU), Pworth: Papworth Hospital, and RMH: The Royal Marsden Hospital.